Clinical Trials on Scleritis in New Zealand
Total 696 results
-
XenoPort, Inc.CompletedMultiple SclerosisUnited States
-
Adamas Pharmaceuticals, Inc.CompletedMultiple Sclerosis | Walking ImpairmentUnited States
-
Nazem AtassiState University of New York - Upstate Medical University; ALS Therapy AllianceCompletedAmyotrophic Lateral SclerosisUnited States
-
Yale UniversityGenentech, Inc.TerminatedMultiple Sclerosis | Radiologically Isolated SyndromeUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingMultiple Sclerosis | Demyelinating Autoimmune Diseases, CNS | Neuromyelitis OpticaUnited States
-
Massachusetts General HospitalNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAmyotrophic Lateral Sclerosis | ALSUnited States, Canada
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, United Kingdom, Austria, Italy
-
GlaxoSmithKlineCompletedAmyotrophic Lateral SclerosisUnited Kingdom, United States, France, Italy
-
Boehringer IngelheimRecruitingScleroderma, SystemicUnited States, Belgium, Korea, Republic of, Australia, China, Taiwan, Spain, Israel, Japan, Mexico, Turkey, Germany, Italy, Brazil, France, Singapore, India, Philippines, United Kingdom, Switzerland, Finland, Greece, New Zealand, Denmark and more
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis | Autoimmune Diseases of the Nervous System | Disease Progression | Secondary Progressive Multiple Sclerosis | Brain AtrophyUnited States, Canada
-
MedImmune LLCCompletedMultiple Sclerosis, Relapsing FormsUnited States, Spain, Poland, Ukraine
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
CelgeneCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Germany
-
MallinckrodtMallinckrodt ARD Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
The Florey Institute of Neuroscience and Mental...The University of Queensland; Mobius Medical Pty Ltd.RecruitingAmyotrophic Lateral SclerosisAustralia
-
United TherapeuticsTerminatedSystemic SclerosisUnited States, Canada, United Kingdom
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Brainstorm-Cell TherapeuticsCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
Acorda TherapeuticsCompleted
-
PDL BioPharma, Inc.CompletedMultiple SclerosisUnited States, Canada
-
Columbia UniversityNovartisActive, not recruiting
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
Acorda TherapeuticsCompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Target ALS Foundation, Inc.RecruitingTarget ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures (TALSLB)Movement Disorders | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Degenerative DisorderUnited States
-
Rutgers, The State University of New JerseyHorizon Blue Cross Blue Shield of New JerseyRecruitingMultiple Sclerosis | Cognitive ImpairmentUnited States
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisSpain, United States, Italy, Switzerland, Germany, Bulgaria, Czechia, Poland, Puerto Rico, Romania
-
CytokineticsTerminatedAmyotrophic Lateral SclerosisCanada, United States, Australia, Spain, Belgium, Ireland, Italy, Netherlands, Sweden
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
University of New MexicoUniversity of California, San DiegoCompletedSystemic SclerosisUnited States
-
BiogenCompleted
-
US Department of Veterans AffairsMuscular Dystrophy AssociationCompletedAmyotrophic Lateral SclerosisUnited States
-
AmgenEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicGermany, Spain, Korea, Republic of, Japan, Mexico, Argentina, Greece, United States, Austria, France, Israel, Poland, United Kingdom
-
Kessler FoundationCompletedMultiple Sclerosis | Traumatic Brain InjuryUnited States
-
Novartis PharmaceuticalsCompletedAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Italy, Netherlands, Switzerland, United Kingdom
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Amylyx Pharmaceuticals Inc.ALS Association; ALS Finding a Cure; Northeast ALS Consortium; Neurological Clinical... and other collaboratorsCompletedCentral Nervous System Diseases | Nervous System Diseases | Neuromuscular Diseases | Neurodegenerative Diseases | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Spinal Cord Diseases | TDP-43 ProteinopathiesUnited States
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Acorda TherapeuticsCompleted
-
Edward KasaraskisNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAmyotrophic Lateral SclerosisUnited States
-
Brian WaingerMassachusetts General Hospital; GlaxoSmithKline; ALS Association; Harvard UniversityCompletedAmyotrophic Lateral SclerosisUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
EMD SeronoTerminatedRelapsing Multiple SclerosisUnited States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Puerto Rico